Investorideas.com newswire, news and commentary for leading sectors

Wednesday, August 24, 2016

Zika Stocks To Watch; $AEMD, $BCRX, $CERS, $INO; Virus Continues Spread

Zika Stocks To Watch; $AEMD, $BCRX, $CERS, $INO; Virus Continues Spread

Point Roberts, WA, Delta BC – August 22, 2016 – Investorideas.com, a global news source and investor resource covering actively traded sectors including biotech and medical technology  stocks , releases its Zika stocks directory for investors following the sector as the virus continues its spread in the US.

As of this week, Florida’s Governor reported five new non-travel-related cases of Zika virus and the first one in the Tampa Bay area, now bringing the total to 42.

CDC report as of August 17, 2016
•Zika virus disease and Zika virus congenital infection are nationally notifiable conditions.
•This update from the CDC Arboviral Disease Branch includes provisional data reported to ArboNET for January 01, 2015 – August 17, 2016.

US States
•Locally acquired mosquito-borne cases reported: 14
•Travel-associated cases reported: 2,245
•Laboratory acquired cases reported:  1
•Total: 2,260 ◦Sexually transmitted: 22
◦Guillain-Barré syndrome: 7
  


The Florida Department of Health has identified two areas in Miami with active transmission of Zika virus. See advice (http://www.cdc.gov/zika/intheus/florida-update.html) for people living in or traveling to these areas.

Zika Virus Stocks
Aethlon Medical, Inc. (NasdaqCM: AEMD) creates innovative medical devices to address life-threatening diseases. The Aethlon ADAPT™ (Adaptive Dialysis-like Affinity Platform Technology) establishes the basis for a new class of therapeutics that target the rapid elimination of disease enabling particles from the circulatory system of treated patients.  The lead Aethlon ADAPT™ product is the Hemopurifier®, a device that addresses a broad-spectrum of viral pathogens as well as tumor-secreted exosomes that suppress the immune system of cancer patients.  Aethlon is also operating under two government contracts with the Defense Advanced Research Projects Agency (DARPA) related the development of a medical device to reduce the incidence of sepsis. Exosome Sciences, Inc. is a majority owned Aethlon subsidiary that is advancing exosome-based strategies to diagnose and monitor cancer and infectious disease progression. 
Aethlon Medical (Nasdaq: AEMD) Announces Zika Virus Data
In vitro studies that demonstrate the rapid capture of Zika virus by the Aethlon Hemopurifier
SAN DIEGO - August 11, 2016- Aethlon Medical, Inc. (Nasdaq: AEMD), a developer of immunotherapeutic technologies to combat infectious disease and cancer, announced today that its researchers have completed in vitro studies that demonstrate the rapid capture of Zika virus by the Aethlon Hemopurifier®. The Hemopurifier® is a leading broad-spectrum treatment countermeasure against viral pathogens that are untreatable with or resistant to antiviral drug therapies. At present, the immunotherapeutic technology is being advanced through an FDA approved human feasibility study. The Zika studies, which were conducted with small-scale versions of the Hemopurifier®, demonstrated a 95% clearance of Zika virus from cell culture fluid in 5.5 hours and an approximate 50% clearance of Zika from human blood serum in 5 hours.
The studies were conducted with the Zika viral strain that has recently spread from South America to ravage Puerto Rico and likely responsible for the first wave of infections that have begun to occur in the United States. Zika has been declared a global health threat by the World Health Organization and is not addressed with a proven drug or vaccine therapy. According to the CDC, more than 7,300 Americans have been diagnosed with Zika virus infection, including 1,825 individuals in the continental U.S. and Hawaii. Researchers have linked Zika virus infection with Guillain-Barre syndrome, a severe neurological disorder that can cause paralysis. In pregnant women, Zika can cause Microcephaly, which results in babies being born with a small head and underdeveloped brain. Zika infection has also been associated with Arthrogryposis, a condition that results in deformities of joints in the arms and legs of newborns.
"As a result of our research team's validation of Zika capture, we have further reinforced the potential of our Hemopurifier® to be a first line of defense against the growing list of infectious viral pathogens that are not addressed with traditional drug or vaccine therapies," stated Aethlon Chairman and CEO, Jim Joyce.
BioCryst Pharmaceuticals (NASDAQ:BCRX) BioCryst Pharmaceuticals designs, optimizes and develops novel small molecule drugs that block key enzymes involved in rare diseases.  BioCryst’s ongoing development programs include oral plasma kallikrein inhibitors for hereditary angioedema; BCX7353 and other second generation compounds, and BCX4430, a broad spectrum viral RNA polymerase inhibitor. In March the Company announced that results from a preclinical study of its broad spectrum antiviral BCX4430 in immune-deficient mice infected with Zika virus would be presented at a World Health Organization (WHO) meeting scheduled to take place March 7-9 in Geneva, Switzerland. The primary goal of the study was to assess the effect of BCX4430 treatment on survival through Day 28 in immune-deficient mice infected with the Zika virus. BCX4430 was administered by intramuscular (I.M.) injection twice a day beginning four hours prior to virus challenge and continuing for eight days; two dose levels were tested. In the standard dose BCX4430 group, 7 of 8 mice survived through Day 28. In the low dose BCX4430 group (n=8), and in control groups administered vehicle placebo (n=8) or ribavirin at two dose levels (n=16), no animals survived to Day 28. Overall survival for the standard dose level of BCX4430 was superior to both the placebo and the ribavirin treatment control groups (p < 0.0001). For both dose levels of BCX4430, median survival was superior to both control groups (>28 days for BCX4430 standard dose and 23 days for low dose) compared to 14 to 17 days for controls. This study was conducted at Utah State University, under the ongoing Animal Models of Infectious Disease Program at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. This program provides in vivo screening services for researchers, as part of a broader suite of preclinical services supported by NIAID. These services are part of NIAID’s infrastructure for responding to emerging infectious diseases, such as Zika virus, and allow for research to be quickly directed to support immediate public health needs.
Cerus Corp. (NasdaqGM: CERS) is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development
GeneOne Life Science Inc. (KSE:011000.KS; KRX:011000.KR) a biopharmaceutical company, engages in the research and development of DNA vaccines to prevent and treat incurable diseases in South Korea and internationally. Its product pipeline includes VGX-3400, a DNA vaccine, which has completed Phase I clinical trials for the prevention of avian influenza; VGX-3500, a prophylactic pre-pandemic influenza DNA vaccine that is in Phase I clinical trials for protection against swine, avian, and seasonal influenza; and FLUPRIME, a trivalent influenza vaccine, which is in Phase I clinical trials for the prevention of the outbreak of seasonal flu. The company is also developing VGX-6150, a therapeutic DNA vaccine that is in Phase I clinical trials for the treatment of hepatitis C; and therapeutic DNA vaccines for the treatment of hepatitis B. In addition, it is involved in the contract manufacturing activities for various pre-clinical and clinical studies for institutions, universities, governments, and biotechnology companies. GeneOne Life Science Inc. has a collaboration with Inovio Pharmaceuticals, Inc. to test and advance a DNA-based vaccine for preventing and treating the emerging and virulent Zika virus infection. The company was formerly known as VGX International Inc.
GLAXOSMITHKLINE  PLC (NYSE:GSK) creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases
Inovio Pharmaceuticals, Inc (NYSE MKT:INO) is revolutionizing the fight against cancer and infectious diseases. Our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. With an expanding portfolio of cancer immunotherapies and clinical studies, the company is advancing a growing product pipeline. Partners and collaborators include Roche, the University of Pennsylvania, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, US Dept. of Homeland Security, and University of Manitoba.

Intrexon Corporation (NYSE:XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet. The Company's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®.
SANOFI-AVENTIS SA (NYSE:SNY; Paris: SAN.PA) a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. https://lehub.sanofi.com/en/access-healthcare/zika-a-strong-sense-of-urgency/

Full biotech stocks directory : http://www.investorideas.com/BIS/stock_list.asp

About Investorideas.com - News that Inspires Big Ideas
Sectors we cover in include mining, energy, renewable energy, water stocks, food and beverage (including organic and LOHAS, wine), defense and security, biotech, technology and mobile. We have also expanded our global coverage to include Latin American stocks, the Middle East, sports and entertainment.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: AEMD - August 11, 2016 - one month of PR. News publication and social media – two thousand five hundred

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411






Tuesday, August 23, 2016

#GopherProtocol (OTCQB: $GOPH) #SocialMedia #GPS #Game, #PUZPIX Now at http://www.puzpix.com


#GopherProtocol (OTCQB: $GOPH) #SocialMedia #GPS #Game, #PUZPIX Now at http://www.puzpix.com

Download on both the Apple store and on GooglePlay under the name PUZPIX



San Diego, California, August 23 , 2016 – (Investorideas Newswire) Gopher Protocol Inc. (OTCQB:GOPH) (“Gopher” and the "Company”), a development-stage Company which specializes in the development of real-time, heuristic-based mobile technologies, and its partners, Guardian Patch LLC (“Guardian”) and Alpha EDA, LLC (“Alpha”), which previously announced on July 27, 2016 that they had completed the design and construction of version I of PUZPIX, a unique social media game based on their GOPHERINSIGHT™ integrated circuit technology, announced today that the PUZPIX website, http://www.puzpix.com/, has been launched and is fully operational.  PUZPIX can be downloaded on both the Apple store and on Google Play under the name “PUZPIX”.

PUZPIX is a social media game based on GOPHERINSIGHT™ technology licensed by the Company. The game uses a computerized framework to create a puzzle from images that users upload onto the system’s server. The user creates an account and has the option to store images in the designated "FRIENDS" area and/or in the designated ALL (public) area. Only approved friends will be granted access to the images in the FRIENDS area and all players have access to the ALL area. Upon a user’s request, the system turns an image into a puzzle of at least nine pieces, though more challenging puzzles can be made once the user achieves a higher level of skill.

As detailed in our recent quarterly report filing with the Securities and Exchange Commission, PUZPIX represents a joint venture between Gopher and Alpha. The Company, Guardian and Alpha have agreed that all Epsilon EDA and PUZPIX intellectual property rights will be assigned to Alpha (Epsilon EDA was developed in connection with the Company's mobile IC technology for the purpose of reducing power consumption and to provide optimal heat control).  Alpha and the Company agreed to enter into a Joint Venture ("JV") agreement similar to the Guardian Patch JV agreement, pursuant to which Alpha will fund all of its operational and developmental needs (software development, support, marketing and administrative) and the profits of Alpha will be distributed equally to the two equal JV partners.  Alpha will hold all intellectual property rights related to software. Currently, two products will be owned by Alpha, the Epsilon software and the PUZPIX social game.

The Company, through Alpha, has also begun initial development and testing on an advanced version II of PUZPIX, which if developed, would include a GPS base tracking technology. The Company envisions that the inclusion of such a tracking technology in PUZPIX would require users to venture outdoors in order to find and collect puzzle pieces. Upon the Company and its partners launching the GopherInsight™ integrated circuit technology, the Company also hopes to develop a version III of PUZPIX to include domestic/ international exchanges of puzzle pieces that could be shared worldwide.

PUZPIX offers its users entertainment, education, interaction and most off all, fun. The experience is even more enjoyable when two or more players collaborate on the same puzzle.  The system offers high-quality sound effects, tactile feedback and other experiences that make it all the more rewarding.”, said Dr. Rittman, the CTO of the Company.  Being a social media game, but still a derivative of the GOPHERINSIGHT™ technology, PUZPIX represents for us a lab prototype examining system that will manage databases of all types including media, textual, graphical and secured communication information.” Continued DR. Rittman. “In addition to our designated Facebook page for PUZPIX (“PUZPIXAPP”), we have also released a short informational video about the game that can be watched on the following link: https://youtu.be/5zrJH827le4 .“, advised Dr. Rittman.


PUZPIX is protected through a patent in connection with the Company's development of a system, method and software application for mobile database management and sharing over a private, secured network. The patent contemplates that a system will manage databases of all types including media, textual, graphical and secured communication information. The system will work with a proprietary integrated circuit (IC) within mobile devices. Working together with the IC and the mobile software application, it is the intent that the system will share all mobile database types with all other, same mobile ICs that are installed on other mobile devices, worldwide, via its own private, secured, encrypted protocol.




About Guardian Patch
The Guardian Patch (the "Patch"), potentially arriving in consumer markets in 2017, is a unique location technology that works with or without GPS.  The Patch is a "stick-on" device that provides its users with the capability to protect and track objects, a loved-one or even a pet, through a mobile application.  Download the Patch app, register your patch, and track it on your mobile device or on our designated website.  Register the Patches of your family members and friends to receive alerts in the event of an emergency.  Peel the Patch off and the Patch acts as a beacon, sending out a signal and notifying anyone who has registered the user's Patch.

About Gopher Protocol Inc.
Gopher Protocol Inc. (OTCQB: GOPH) (“Gopher” and the "Company") (http://gopherprotocol.com/) is a development-stage company developing a real-time, heuristic-based mobile technology.  Upon development, the technology will consist of a smart microchip, mobile application software and supporting software that will run on a server.  The system contemplates the creation of a global network.  Gopher believes this will be among the first system that is developed using a human, heuristic-based analysis engine.  Since the core of the system will be its advanced microchip technology that will be capable of being installed in any mobile device worldwide, Gopher expects that this will result in an internal, private network between all mobile devices utilizing the microchip by providing mobile technology for computing power enhancement, advanced mobile database management/sharing and other additional mobile features.

Corporate Site: http://gopherprotocol.com


Consumer and product website for Guardian Patch: http://www.guardianpatch.com/.

Consumer and product website for PuzPix: http://www.puzpix.com/

Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

Contact:
Danny Rittman CTO
Gopher Protocol Inc.
VM Only - 888-685-7336

Visit this company: http://gopherprotocol.com/

More info on GOPH at Investorideas.com Visit: http://www.investorideas.com/CO/GOPH/

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Sign up for free news alerts

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR , social media and publishing client and compensates Investorideas.com ( three months effective April 4, 2016- three thousand five hundred per month )

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.






Monday, August 22, 2016

#CYPRIUMMINING @CypriumMining (#TSX: $CUG.V) ANNOUNCES OXIDE ZINC ASSAYS RESULTS AVERAGING 30.2%

#CYPRIUMMINING @CypriumMining (#TSX: $CUG.V) ANNOUNCES OXIDE ZINC ASSAYS RESULTS AVERAGING 30.2%



Montreal, Quebec - August 22, 2016 – (Investorideas Newswire) Cyprium Mining Corporation (“Cyprium” or the “Company”) (TSX-V: CUG) is pleased to announce the results from additional underground samples taken from an oxidized zinc body on level 14 as part of its ongoing exploration program of the Potosi silver mine located in the historic Santa Eulalia, Mexico.

The thirty six samples were taken from two historic stopes on level 14 of the Santo Domingo body, and averaged 30.2% Zn over an average sample width of 3.00 m.  Two samples assayed less than 10% zinc and two samples were below detection levels for the zinc assay utilized, and 0 was used in the calculation of the average.  If the two samples with zinc assays below detection are left out, the average is 32.0% zinc for the remaining 34 samples. 

Assay results for nine samples of similar zinc oxide material from a third smaller stope on the same level assayed 37% zinc as previously announced (see News Release of June 20, 2016).  The oxide zinc material is mainly hemimorphite, a zinc silicate mineral, and contains variable but generally low concentrations of lead, iron, manganese and arsenic. Oxidized zinc material is different from the more usual zinc sulfide produced by flotation in most zinc mines and requires different processing techniques to recover the zinc metal. The results announced today are part of an ongoing exploration program to evaluate the potential of known mineralized areas.

Mr. Alain Lambert, Chairman and CEO of Cyprium commented: “The three areas where we are currently focusing our exploration efforts inside the mine are the Tunel body at level 2 to 4, the oxide zinc body on level 14 and the sulfide mineralization in the Santo Domingo body, also known as Main Silicate body. The Santo Domingo body, which was partly mined in the past on levels 6, 9, 10 and 11, assumes top priority in terms of evaluation and preparations for exploitation.”

Results of sampling from the Santo Domingo body taken during the due diligence period prior to the acquisition of a controlling interest in the Company’s Potosi joint venture, were previously announced and showed significant silver, lead and zinc values (see News Releases of August 12th and September 3rd, 2015) as summarized in the table below. 


AREA
SAMPLES
Width
Ag g/t
Pb%
Zn %
Fe%
Mn%
Level 6
3
1.53
733
1.1
0.5
7.78
1.31
Level 9
10
1.12
246
4.3
4.3
2.97
1.18
Level 10
15
1.16
78
3.3
4.1
8.39
0.61
Level 11
9
1.84
45.5
2.0
4.1
2.76
0.11
Weighted averages for samples from the Santo Domingo body and released previously as indicated in text.

The primary objective of the 2015 exploration program at level 9 and 10 was to audit past exploration results from over five hundred samples taken in 2014 by an independent third-party. The audit sampling included taking twenty-five duplicate samples of the 2014 program.

The sample audit consisted of ten samples from level 9 and fifteen samples from level 10. The ten samples from level 9 gave a weighted average of 246 g/t Ag, 4.3% Pb and 4.3% Zn over an average sample width of 1.12 meters, while those taken by the independent third party yielded averages of 290 g/t Ag, 5.46% Pb and 3.45% Zn for the corresponding samples. The fifteen samples from level 10 yielded 78 g/t Ag, 3.3% Pb and 4.1% Zn over an average sample width of 1.16 meters, while those taken by the independent third party yielded 187 g/t Ag, 3.44% Pb and 4.31% Zn. The Company does not have laboratory certificates or analytical methods for the third party samples.

The 2015 underground exploration program also consisted of thirteen channel samples taken on level 6 and 11 of the mine. Three samples from level 6 gave a weighted average of 733 g/t Ag, 1.12% Pb and 0.53% Zn over an average sample width of 1.53 meters, while a sample taken from a stockpile located on level 6 yielded 376 g/t Ag, 0.75% Pb and 1.66% Zn. The nine samples from level 11 yielded 45.5 g/t Ag, 2.02% Pb and 4.10% Zn over an average sample width of 1.84 meters.

The Santo Domingo body is not accessed by the recently rehabilitated Potosi No. 3 shaft that will be used to provide services such as compressed air and for haulage of broken mineralized rock from Tunel body on levels 2-4 (see News Releases of June 9 and Jun13, 2016) where underground exploration and development has begun.  Past production from the Santo Domingo body was from the Potosi No. 1 and Potosi No. 5 shafts and from the Buena Tierra shaft on neighboring ground controlled by Grupo Mexico. Proposals for gaining shaft access to the Santo Domingo body are currently in consideration. 

Mineralization in the area is exposed in a large chimney that extends over several levels. Although most of the mineralization on the upper levels of the Potosi mine is oxidized, local areas with preserved sulfides on the upper levels were discovered in the last few decades (1).  The main exposures of sulfide mineralization studied to date are on levels 9 to 11, but the sulfide material also extends upward to level 6. Such sulfide orebodies were not economically exploitable prior to the advent of selective flotation in the early 1900’s and were evidently left behind for this reason and later forgotten.  These “perched” sulfide bodies were possibly preserved due to the vagaries of past oxidation.

Efforts are underway to determine the volume and grades of remaining sulfide material as part of a NI 43-101 resource calculation planned by the end of the year. 



Composite level map of the Potosi Mine showing areas projected for exploration.
The workings discussed in this press release are shown on a composite projection in different colors for each level, and include the main adit and 0 level tunnel, Potosi shafts No. 3 and No. 1, and the stopes on levels 2-4 (Tunel body), 6 and 9-10 (Santo Domingo or Main Silicate body).

The Santa Eulalia District
Santa Eulalia is a world class polymetallic mining district located in the central part of the State of Chihuahua, Mexico, approximately twenty-two kilometers east of the City of Chihuahua. Mineralization in the area was originally discovered during the Spanish colonial period in the 1500’s, and recorded production has occurred over more than 300 years. Santa Eulalia ranks as one of Mexico's primary silver and base metal producing districts with nearly 450 million ounces of silver and substantial amounts of lead and zinc mined. The nature of the deposit in the Santa Eulalia district is a carbonate replacement deposit and is the historically largest of its type in Mexico. Mineralization occurs in an area about 10 km in length and 5 km in width.  Production and reserves for the district have been estimated to be about 50 million metric tons (2) with grades of 125-350 g/t Ag, 2-8% Pb and 3-12% Zn (2) (3), along with appreciable quantities of tin and vanadium. 

The Santa Eulalia district covers approximately forty-eight square kilometers and is divided into three areas, the West Camp, the Central Camp and the East Camp. The Potosi silver mine is located in the West Camp. The West Camp has produced most of the minerals from the district from an area 4 km long in a north-south direction and 2 km wide in an east-west direction, with the Potosi silver mine being one of the primary producers.

Based on the geology, past mining activity and the exploration work completed by the Company to date, the Potosi mine, the Company believes that the project warrants further exploration. Widely spaced sampling on levels 3-4 in the area of the Potosi #3 shaft (Tunel body) and levels 6 and 9-11 in the area of the Potosi #1 shaft (Santo Domingo or Main Silicate body) has shown that mineralized material of interesting grades is exposed at the margins old stopes and adjacent areas, and this work will continue in order to evaluate the potential for defining resources. 

Geological Setting, Deposit Type and Mineralization
Mineralization in the Santa Eulalia district is characterized by massive sulfides, dominantly pyrrhotite, sphalerite, galena and pyrite that are hosted mainly in horizontal mantos and steep chimneys of sulfide material that replace limestone, with some breccia bodies also occurring.  Mineralized bodies occur along laterally continuous discrete structural zones that mainly trend in a north-south orientation, with mineralization forming preferentially in certain stratigraphic units.  Past mining has reached to as much as 700 meters depth below the surface on 21 levels.  Production in the West camp was diminished until the late 80’s with the discovery of new mineralization.  Currently there is little production in the district.

National Policy 43-101 Report
Cyprium has recently filed on SEDAR a National Instrument 43-101 report with respect to the initial mine levels 2, 3 and 4 of the Potosi silver mine.  The report, prepared by Dr. Craig Gibson, does not contain a resource or reserve calculation.

Quality Assurance and Control
Samples taken in underground workings are typically channel samples.  Sample cuttings consist of rock chips taken along pre-marked channels approximately 15-20 cm in width that span the mineralized zone and are collected at the site by an experienced sampling crew under the supervision of a Company geologist.  Sample material, consisting of 1.4 to 3 kg of material, was placed in labelled plastic bags that sealed with ties at the collection site.  The samples are then transported from the mine and stored at the Company’s or contractors surface facilities or are taken directly to the lab preparation facility.  The samples are transported in Company vehicles and delivered to the sample preparation facility by personnel of the contractor. 

All samples were analyzed in Vancouver for the reported metals except zinc by the ME-OG62 method for higher grade samples.  Zinc was analyzed by the Zn-VOL50 potentiometric titration method using a 4 acid digestion.  For these initial high grade samples, only blanks were used as internal control samples, and the laboratory applies strict quality control procedures.  ALS Chemex is part of ALS Global, an internationally recognized analytical laboratory. 


About Cyprium Mining Corporation
For further information, please contact:
Alain Lambert, Chairman and C.E.O.
E-mail:        
alambert@cypriummining.com  Phone:    + 1 514 219 7988 or + 52 1 614 253 5803

Ron Keenan, C.O.O.
E-mail : rkeenan@cypriummining.com  Phone + 1 514 915 3836


800 René Lévesque West                                            Paseo Bolivar 303    
Suite 425                                                                  Centro Historico
Montréal, Québec               www.cypriummining.com   Chihuahua, Chihuahua
H3B 1X9, Canada               TSX-V: CUG and CUG.DB    Mexico


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Qualified Person: Dr. Craig Gibson, Certified Professional Geologist, prepared the summary of public historical information on the Santa Eulalia district, and has reviewed the appropriate portions of this news release and approved the contents thereof.  Public information included in this release are based on work by from a PhD dissertation by Peter K. M. Megaw and information from the Mexican Geologcial Survey (Servicio Geologico Mexicano).

References:
(1) P. Megaw, pers. Comm.

(2) Megaw, P.K.M., 1990, Geology and geochemistry of the Santa Eulalia mining district, Chihuahua, Mexico, unpublished PhD dissertation, University of Arizona, 461 pp.

(3) Bustos-Diaz, J.L. and Arzabala-Molina, J., 2007, Monografia Geologico-Minera del Estado de Chihuahua, Servicio Geologico Mexicano, 640pp.

This news release contains "forward-looking information" (within the meaning of applicable Canadian securities laws) and "forward -looking statements" (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as "anticipate", "believe", "expect", "plan", "intend", "potential", "estimate", "propose", "project", "outlook",  "foresee" or similar words suggesting future outcomes or statements regarding an outlook. Such statements include, among others, those concerning the Company’s anticipated plans for developments of the Company and its mining projects”.

Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Assumptions have been made regarding, among other things, management's expectations regarding future growth, plans for and completion of projects by Company’s third party relationships, availability of capital, and the necessity to incur capital and other expenditures. Actual results could differ materially due to a number of factors, including, without limitation, operational risks in the completion of Company’s anticipated projects, delays or changes in plans with respect to the development of Company’s anticipated projects by Company’s third party relationships, risks affecting the ability to develop projects, risks inherent in operating in foreign jurisdictions, the ability to attract key personnel, and the inability to raise additional capital. No assurances can be given that the efforts by the Company will be successful. Additional assumptions and risks are set out in detail in the Company’s MD&A, available on SEDAR at www.sedar.com.

Although the Company believes that the expectations reflected in the forward-looking information or statements are reasonable, prospective investors in the Company's securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise this forward-looking information and statements except as required by law. Investors should note that the Potosi silver mine and La Chinche property have no established mineral resources or mineral reserves as defined by NI 43-101. Although Cyprium Mining has made a production decision regarding the Potosi silver mine based on historical production records and results from recent sampling, a feasibility study of its projects has not been completed and there is no certainty that the proposed operations will be economically or technically viable.

Visit this Company: www.cypriummining.com    

More info on CUG.V at Investorideas.com: http://www.investorideas.com/CO/CUG/

Sign up for the free investor news and stock alerts:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.  Disclosure: Cyprium Mining Corporation: six month news, PR and social media mining program for 9700 starting August 12, 2016

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.




InvestorIdeas.com Newswire